OptiNose Inc OPTN.OQ OPTN.O is expected to show a rise in quarterly revenue when it reports results on March 20 for the period ending December 31 2024
The Yardley Pennsylvania-based company is expected to report a 12.3% increase in revenue to $22.307 million from $19.87 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.The company's guidance on November 12 2024, for the period ended December 31, was for revenue between $19.00 million and $23.00 million.
LSEG's mean analyst estimate for OptiNose Inc is for a loss of 72 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for OptiNose Inc is $17.50, above its last closing price of $5.88.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -0.79 | -0.79 | 0.00 | Beat | 100 |
Jun. 30 2024 | -1.11 | -1.16 | -0.75 | Beat | 35.3 |
Mar. 31 2024 | -1.63 | -1.61 | -1.80 | Missed | -11.6 |
Dec. 31 2023 | -1.42 | -1.41 | -1.35 | Beat | 4.6 |
Sep. 30 2023 | -1.42 | -1.41 | -1.20 | Beat | 15.2 |
Jun. 30 2023 | -1.61 | -1.63 | 0.30 | Beat | 118.4 |
Mar. 31 2023 | -2.06 | -2.09 | -2.55 | Missed | -22 |
Dec. 31 2022 | -2.60 | -2.62 | -2.55 | Beat | 2.7 |
This summary was machine generated March 18 at 12:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。